Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have a hard time believing these little 100 share, even 1000 share trades are legit retail shareholders. $3, even $30 trades?
Ready for a Dexcel update too but no telling when that happens.
Let’s go!
People love on a sale on anything… except stocks.
Excellent Q
“Want to walk away” lol
So do so?
When do we get abuse study results, next week??
A whistleblower? Lol
Bshr% rising, upward move likely
Yes any company can fail. Some are much more likely to than others. We don’t have anywhere near the crushing debt that Lannett has/had. The recent bank loan Elite obtained to purchase their property is about $12 million, meanwhile Lannett is over half a billion dollars in debt.
Interesting.
Too uncertain right now with sales and marketing division being built from the ground up. Need a few quarters to see if we can meet/exceed historical numbers.
That’s old, from 2016 right? I know someone posted about the more recent ruling on Purdue patents and Intas pharma or whatever it’s called.
I still want to know how the generic Oxy ANDA works. We filed in what, 2017 but then the FDA came out with abuse study requirements + the patent issues? Once we complete the insufflation study Nasrat referenced, does the FDA then start processing that application toward approval? Or are we still bound by Purdue’s patents?
Anyone know?
CONGRATS
k.
CONGRATS AGAIN, CMDAWG!
So we don’t want people buying shares? Lol ok. Now I’m def confused.
Not sure, gotta see where we land. If I see some panic selling that I don’t feel is warranted, I’d snag low .02s if it got that low. Got some mid 3s and high 2s this year already.
No way to know how the share price will react to the next quarterly/yearly report. We have had revenue gains and profits, some larger than others, in nearly every quarter for how many years now? And the price has still repeatedly declined. So I don’t think it’s crazy to suspect the price could also decline further after we see a drop in revenues while we build up internal sales and marketing division.
Additionally, Roths have relatively low annual contribution limits so trying to time my buys well.
I saw that fat chunk of volume go through, congrats dude!
I’ve got some powder I’m keeping dry in the Roth just in case we see some shenanigans after they report on this current quarter.
Question is, does this open the flood gates for other generic Oxy ANDAs (like ours) to be approved?
Or is this only narrowly applicable to Intas Pharma’s Oxy?
NYSE to Suspend Trading Immediately in Lannett Company, Inc. (LCI) and Commence Delisting Proceedings
April 19, 2023, 4:30 PM EDT
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Lannett Company, Inc. (the “Company”) - ticker symbol LCI - from the NYSE. Trading in the Company’s common stock will be suspended immediately.
NYSE Regulation reached its decision to delist the Company’s common stock pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000.
The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the common stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230419005997/en/
Plus like NH said on the last call, it’s hard to project revenues and such on these products years out when you don’t know what the competitor landscape will look like yet. Maybe a given ANDA is worth the development money spent, maybe not and we end up divesting it.
Well, you don’t know what the stock price would do after announcing and completing a buyout either but you 100% would reduce the supply of shares and that SHOULD lead to a rise in price.
I actually agree and included that as a question. Near all time lows - maybe not right this second but at these levels, once the S&M arm is built and stable….
Buyback will probably never be as cheap, or as easy, or go as far with the money spent as now.
A million bucks is 33,333,333 or thereabouts at .03 right now, maybe less whatever associated costs? Plus the press of doing that could completely change the sentiment.
My man.
Only a couple more days until Elite is officially out on its own for sales and marketing - interested to see how this plays out.
I mean read the board? Lol. Pretty easy to see who.
But I keep being told this company is worthless, so which is it?? LOL.
Literally can’t have it both ways.
He’s the largest shareholder. Stands to gain way more by the share price rising / company being bought out by someone other than him. Lol.
I’ve yet to hear anyone convincingly explain how him taking over the company cheap makes him more money than selling the company to someone else. He’s got what, over 300,000,000 shares? I don’t even know the number anymore, some insane amount.
My post did not make any specific accusations, only a general consensus on the ridiculous naysaying despite how Elites management continues to work on improving business operations and fundamentals !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Where did I praise management in that post?
Agreed. Only so much downside at 3 cents considering all the assets the company has vs. $3 or whatever post split number we’d arrive at. Same reason they called off the Mikah Adderall deal, too much uncertainty right now although I believe the eventual outcome will be positive.
Agree, need institutional involvement with a worthwhile amount of share ownership that won’t happen on the OTC.
Wish we could uplist without the RS though.
No kidding. From what I read, bad bond investment, considering inflation + 42B worth of customer withdrawals in a panic = SVIB belly up. Rip
Agree! Fair post. Let’s get this bad boy rollin.
Let’s hope! Got at least 1 order set slightly lower than here in the event that it dips further. Kinda waiting to see how our first 1-2 quarters post Lannett goes.
Good luck. Def shouldn’t hold anything that makes ya lose sleep over it. It’s been a long road, here’s to hoping this does pan out in our favor before too much longer.
Same! $ELTP$